Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
Titel:
Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
Auteur:
Fanouriakis, Antonis Adamichou, Christina Koutsoviti, Sofia Panopoulos, Stylianos Staveri, Chrysanthi Klagou, Anastasia Tsalapaki, Christina Pantazi, Lamprini Konsta, Styliani Mavragani, Clio P. Dimopoulou, Despoina Ntali, Styliani Katsikas, Georgios Boki, Kyriaki A. Vassilopoulos, Dimitrios Konstantopoulou, Pinelopi Liossis, Stamatis-Nick Elezoglou, Antonia Tektonidou, Maria Sidiropoulos, Prodromos Erden, Abdulsamet Sfikakis, Petros P. Bertsias, George Boumpas, Dimitrios T.